Minoxidil 5 mg oral versus Minoxidil 5% topical solution for Male Pattern Baldness: randomized clinical trial

Not Applicable

• Conditions: male androgenetic alopecia; C17.800.329.937.122; L64.9

• Registration Number: RBR-252w9r
• Lead Sponsor: niversidade Estadual Paulista Julio de Mesquita Filho

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-02-09
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

We will select ninety male patients aged between 18 and 55 years with the diagnosis of male androgenic alopecia, classified in the Norwood Hamilton scale as 3V, 4V or 5V, informed and agreeing to participate in the research.
The diagnosis of male androgenic alopecia will be based on clinical, dermoscopic and histopathological criteria.

Exclusion Criteria

Patients who have had previous hair loss treatment in the last 6 months, hypertensive patients, heart disease, nephropaths, other causes of hair loss or scalp dermatosis will not be eligible to participate in the study.

Study & Design

• Study Type: Intervention
• Study Design: Not specified